IFF Pharma Solutions Unveils Breakthrough Research at AAPS 2024 PharmSci 360
Rhea-AI Summary
IFF Pharma Solutions will showcase breakthrough research at AAPS 2024 PharmSci 360 in Salt Lake City, Utah, from Oct. 20-23. The company will demonstrate the critical role of excipients in drug formulation through scientific posters and presentations. Key advancements include:
- Nitrosamine risk mitigation
- Controlled-release performance
- Extrusion spheronization processibility and pellet quality
- Softgel stability
- Formulation of plant-based pharmaceutical gummies
IFF experts will present research on topics such as immediate-release solutions, controlled release matrix tablet formulations, and analytical methods for detecting nitrites in pharmaceutical excipients. The company aims to empower pharmaceutical manufacturers to develop safer, more effective formulations.
Positive
- IFF is presenting breakthrough research at a major industry event, demonstrating innovation leadership
- The company is showcasing advancements in critical areas of drug formulation and delivery
- IFF's research aims to improve drug safety and effectiveness, potentially increasing market competitiveness
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IFF gained 2.42%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Attendees can explore the pivotal role of excipients in drug delivery and gain exclusive insights
"Our latest research underscores IFF's unwavering commitment to pushing the boundaries of industry knowledge and innovation," said Paula Garcia Todd, global application development and innovation leader, Pharma Solutions, IFF. "By leveraging our deep expertise in polymers and excipients, we're empowering pharmaceutical manufacturers to develop safer, more effective formulations that keep them at the forefront of an ever-evolving industry."
Showcasing Science-Backed Technologies
IFF experts will demonstrate how excipients can support the formulation and manufacturing of safe drug products and present novel research on nitrosamine formation kinetics at the following sessions.
- Tuesday, Oct. 22, 10:30 to 11:30 a.m. Mountain Time (MT) - Two scientific posters will offer new insights into immediate-release solutions. Yeli Zhang Ph.D., senior lead applications scientist, will present "The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization." Jin Zhao Ph.D., lead scientist, will present plant-based softgel superior performance in heat tolerance and stability compared to gelatin capsules under various aging conditions with his poster "Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications."
- Tuesday, Oct. 22, 12:30 to 1:30 p.m. MT - Nasrin Mahmoudi Ph.D., senior lead application scientist will present "Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs," showcasing the development of a safe and robust controlled release matrix tablet formulation for active pharmaceutical ingredients (APIs) with vulnerable amines.
- Wednesday, Oct. 23, 10:30 to 11:30 a.m. MT on 360 Stage #3 exhibit hall - Koudi Zhu, senior analytical scientist, will discuss a highly sensitive two-dimensional ion chromatography mass spectrometry (2D-IC/MS) method for detecting trace nitrite in hydroxypropyl methylcellulose (HPMC) with her presentation "Analytical Method Advances in Measuring Nitrites in Pharmaceutical Excipients."
- Wednesday, Oct. 23, 11:30 a.m. to 12:30 p.m. MT - Mark Dreibelbis Ph.D., senior research and development scientist, will share findings that explore the hydrophilic polymer properties that predict controlled-release performance of matrix tables with "Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature."
Audience members attending poster sessions can expect exclusive insights on how different carrageenan grades affect the properties of pharmaceutical gummy formulations, and the role of lubricant ingredients in enhancing the stability of tablet pectin coatings.
- Monday, Oct. 21, 2:30 p.m. MT - "Formulation and In Vitro Evaluation of Carrageenan Based Gummies" by Dr. Nasrin Mahmoudi.
- Wednesday, Oct. 23, 12:30 p.m. MT - "Impact of Lubricant on Functional Tablet Coatings Containing Pectin" by Becca Putans, Ph.D., lead scientist.
To learn more, book a meeting with the IFF Pharma Solutions team at booth #2705 here, or visit the Knowledge Hub to discover IFF's proprietary research and latest scientific posters.
Welcome to IFF
At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, X (Twitter) , Facebook, Instagram, and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Contact:
Emily Kaufman
Global Communications Specialist
+1 908-670-5691
emily.kaufman@iff.com
SOURCE IFF
FAQ
What is IFF Pharma Solutions presenting at AAPS 2024 PharmSci 360?
When and where is IFF (NYSE:IFF) showcasing its research at AAPS 2024 PharmSci 360?
What specific topics will IFF (NYSE:IFF) experts present on at AAPS 2024 PharmSci 360?
How does IFF's (NYSE:IFF) research at AAPS 2024 PharmSci 360 benefit pharmaceutical manufacturers?
